SuperworthAtossa Therapeutics shares outstanding ATOS
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 8.9M
- On a year earlier
- +3.3%
- more shares
Atossa Therapeutics had 8.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 8.6M | +2% |
| FY2024 | 8.4M | +1% |
| FY2023 | 8.4M | −1% |
| FY2021 | 8.4M | +658% |
| FY2020 | 1.1M | +83% |
| FY2019 | 608.7K | +61% |
| FY2018 | 378.5K | +196% |
| FY2017 | 127.8K | +508% |
| FY2016 | 21K | +82% |
| FY2015 | 11.5K | +27% |
| FY2014 | 9.1K | +38% |
| FY2013 | 6.6K | +11% |
| FY2012 | 5.9K | +42% |
| FY2011 | 4.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 8.9M | +3% | |
| Q1 FY26 | 8.6M | +0% | |
| Q4 FY25 | 8.6M | +2% | |
| Q3 FY25 | 8.6M | +3% | |
| Q2 FY25 | 8.6M | +3% | |
| Q1 FY25 | 8.6M | +3% | |
| Q4 FY24 | 8.4M | +1% | |
| Q3 FY24 | 8.4M | −0% | |
| Q2 FY24 | 8.4M | −1% | |
| Q1 FY24 | 8.4M | −1% | |
| Q4 FY23 | 8.4M | n/a | |
| Q3 FY23 | 8.4M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Atossa Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.